SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Invetech Makes Debut, Announces its Exhibiting at the Society for Biomolecular Sciences’ 12th Annual Conference

Invetech
31 Aug 2006
Kerry Parker
CEO

Product news

Invetech, a leading engineering services company specializing in custom automation and instrument development, announces it will be exhibiting at the Society for Biomolecular Sciences’ 12th Annual Conference and Exhibition. The company will be demonstrating its expertise in automation and integration from large scale laboratory systems to benchtop instruments, on booth #107.

Invetech is an engineering services company with extensive experience in solving automation challenges for laboratories and instrument companies working in life sciences, diagnostics and pharmaceutical/biotech laboratories. With a track record in improved reliability, durability and system throughput, the company's expertise crosses a number of disciplines crucial to the drug discovery process including liquid handling, plate handling, robotics, software interfaces, optics, robotics, specialized detection systems, miniaturization, and
integration.

The Society for Biomolecular Sciences’ 12th Annual Conference and Exhibition is an annual event taking place on September 17 – 21, 2006 in Seattle, Washington. The theme of this year’s exhibition focuses on Advancing Drug Discovery and the importance of existing and emerging technologies to improve the quality of patient care.

Paul Dovile, Manager of Life Sciences, Robert Speziale, Vice President of Business Development and Jari Palander, Vice President of Operations, North America, will be representing Invetech at the conference and will be available to discuss Invetech’s engineering expertise.

For more information about Invetech’s innovative instrument development techniques and custom automation services, please contact Invetech by clicking 'request info', visit the article webpage, phone East Coast US: +1 203 675 4502, West Coast US: +1 415 533 1958, or visit on booth #107 at the Society for Biomolecular Sciences’ 12th Annual Conference and Exhibition.

Links

InvetechCompany website

Tags

Lab-on-a-ChipLab-on-a-chip (LOC) technology uses microfluidic chips, such as microarrays, to perform biochemical assays on a small scale. Benefits of lab-on-a-chip include the small volume of sample required as well as the speed of analysis. In selecting lab-on-a-chip devices consider the assay, cost, reliability, sensitivity and signal to noise ratio.High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Microplate Readers / DetectorsMicroplate readers are used to automate the detection and analysis of labeled or label-free components in microplates during assays or live-cell monitoring. Microplate readers are generally distinguished by their mode of detection. Types include absorbance, luminescence, fluorescence intensity, fluorescence polarization, TRF / FRET and multimode microplate readers. Microplate readers deliver a high throughput of samples by reading multiple wells simultaneously, with the 96-well format the most commonly used. As a result, microplate readers are often used in the drug discovery, bioassays, research and pharmaceutical industries for screening applications. Microplate loading can also be automated, with robotic microplate stackers to increase throughput. Find the best microplate readers in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Integration ServicesIncorporate lab systems, software and equipment with integration services.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.

Related articles